Agarwal Fortune India Limited reported a net profit of ₹3.01 lakh for the first quarter of FY27 (Q1FY27), ending June 30, 2026, driven by a significant reduction in stock purchases despite a sharp decline in revenue. The profit represents a 137% quarter-on-quarter increase from ₹1.27 lakh in the preceding quarter, while earnings per share (EPS) rose to ₹0.09 from ₹0.04. The Board of Directors approved the unaudited financial results on August 12, 2026, alongside key governance appointments including the re-appointment of Mr. Mahesh Kumar Agarwal as Managing Director.

The company’s revenue from operations fell 82% year-on-year to ₹39.10 lakh, down from ₹214.46 lakh in Q1FY26. This contraction was primarily due to a decrease in purchases of stock-in-trade, which dropped to ₹136.67 lakh from ₹230.80 lakh in the same period last year. Total expenses decreased proportionally to ₹36.09 lakh from ₹211.31 lakh, allowing the company to maintain profitability. The statutory auditor, M/s Jethani & Associates, issued a limited review report with an unmodified opinion on the financial statements.

Financial Performance

Key Operational Metrics

• Cost Management: Purchases of stock-in-trade reduced by 41% year-on-year to ₹136.67 lakh, contributing to lower total expenses.
• Inventory Changes: The company recorded a positive change in inventories of ₹108.69 lakh, compared to ₹29.58 lakh in Q1FY26.
• Finance Costs: Finance costs increased slightly to ₹4.53 lakh from ₹4.13 lakh in the corresponding period last year.

Corporate Governance Updates

During the board meeting held on August 12, 2026, several governance matters were approved subject to shareholder approval at the upcoming Annual General Meeting:

• Statutory Auditor: M/s Jethani & Associates was re-appointed as Statutory Auditor for FY27. The firm holds a valid Peer Review Certificate valid until August 31, 2028.
• Internal Auditor: M/s ASAR & Associates was re-appointed as Internal Auditor for FY27.
• Managing Director: Mr. Mahesh Kumar Agarwal was re-appointed as Managing Director for a five-year term commencing July 22, 2027, to July 21, 2032.
• Related Party Transactions: Limits for related party transactions under Section 188 of the Companies Act, 2013, were approved for FY27.

What the Numbers Show

The divergence between revenue decline and profit growth highlights a shift in operational scale rather than margin expansion. With revenue dropping 82% year-on-year but net profit remaining relatively stable (down only 6% YoY), the company appears to be operating with significantly lower inventory turnover. The absence of material consumed costs and minimal employee benefit expenses suggest a lean operational model focused on trading activities with reduced volume exposure in Q1FY27.

Agarwal Fortune India Ltd has closed its trading window for all Directors, Designated Employees, and Connected persons effective July 1, 2026, to comply with regulatory norms ahead of its quarterly financial announcement. The restriction will remain in force until 48 hours after the dissemination of the unaudited financial results for the quarter ended June 30, 2026. This measure is implemented in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended by the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018.

The company stated that all designated individuals and their immediate relatives have been instructed not to trade in the securities of agarwal fortune during this closure period. The specific date for the Board meeting to approve the unaudited financial results for the quarter ended June 30, 2026, has not yet been announced and will be communicated in due course.

Trading Window Schedule

The following table outlines the key dates and restrictions related to the trading window closure:

The closure ensures compliance with insider trading regulations by preventing the trading of securities by insiders while they are in possession of unpublished price-sensitive information (UPSI). The company will notify the stock exchanges regarding the Board meeting date for the results approval as per regulatory requirements.